Previous Article | Next Article ![]()
Infection and Immunity, May 2001, p. 3128-3134, Vol. 69, No. 5
Division of Infectious Diseases, University
of Cincinnati College of Medicine, and Cincinnati Veterans Affairs
Hospital, Cincinnati, Ohio
Received 8 December 2000/Returned for modification 24 January
2001/Accepted 31 January 2001
We previously reported that immunization with H antigen from
Histoplasma capsulatum did not protect mice against an
intravenous challenge with yeasts. Here, we investigated the utility of
H antigen to protect mice in a model of pulmonary histoplasmosis. Mice
immunized with H antigen and challenged intranasally 4 weeks postvaccination were protected against sublethal and lethal challenges with H. capsulatum yeasts. If the challenge was
performed 3 months after vaccination, there was a reduction in fungal
burden following sublethal challenge and a modest delay in mortality in
mice given a lethal inoculum. Vaccination was associated with
production of gamma interferon, granulocyte-macrophage
colony-stimulating factor, interleukin-4, and interleukin-10 by
splenocytes. Vaccination with H antigen was not accompanied by a major
expansion of CD4+ or CD8+ cells in spleens of
mice. These results demonstrate that H antigen may be useful as a
protective immunogen against pulmonary exposure to H.
capsulatum.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.5.3128-3134.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Protective Efficacy of H Antigen from
Histoplasma capsulatum in a Murine Model of
Pulmonary Histoplasmosis
*
Corresponding author. Mailing address: Division of
Infectious Diseases, Dept. of Medicine, University of Cincinnati
College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0560. Phone: (513) 558-4704. Fax: (513) 558-2089. E-mail:
george.deepe{at}uc.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»